LONDON, March 9, 2026 /PRNewswire/ -- The "Cell and Gene Therapy Manufacturing Market – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032" report has been added to the Credence Research ...

The partnership will automate manufacturing of ProT-096, a personalized progenitor T-cell therapy for refractory leukemia and ...

Cell and Gene Therapy Manufacturing QC Market · GlobeNewswire Inc. Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Manufacturing QC Market - Global Industry Size, Share, Trends, ...

OrganaBio buys operating assets of Excellos, establishes a coast-to-coast cell therapy contract testing, development and manufacturing organization: Miami ...

Personalized cell therapies have emerged as powerful treatments for cancers and other diseases but producing them remains a complex engineering challenge. Unlike conventional drugs, each cell therapy ...

Since the first FDA approval of a CAR T-cell therapy in 2017, 1 the cell and gene therapy field has seen substantial market expansion. Manufacturing alone is projected to grow at an annual rate of 30% ...

When it comes to cell-based therapy manufacturing, the concept of quality management carries important distinctions from more traditional therapeutics production. Of course, the same rigour is needed, ...

In cell therapy applications, commonly employed cell purification platforms for large-scale isolation of immune or stem cells separate cells based on a single cell surface antigen. Enrichment based on ...

InVitria, a global leader in chemically defined, animal-origin-free recombinant proteins for advanced therapy manufacturing, ...

The University of Texas MD Anderson Cancer Center and CTMC, a joint venture between UT MD Anderson and Resilience, today ...